NCT03120403View on ClinicalTrials.gov

Safety and Efficacy of Intrathecal Morphine in Children

PHASE2CompletedINTERVENTIONAL

Enrollment

45

Participants

Timeline

Start Date

July 1, 2016

Primary Completion Date

March 30, 2017

Study Completion Date

March 30, 2017

Conditions

Abdominal Cancer

Interventions

PROCEDURE

intrathecal morphine

All Listed Sponsors

lead

Alaa Ali Mohamed Elzohry

OTHER

NCT03120403 - Safety and Efficacy of Intrathecal Morphine in Children | Biotech Hunter | Biotech Hunter